Leuprolide Acetate Kit
Product Images NDC 83634-454
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 83634-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Leu0f 0000 02)
Figure B (Leu0f 0000 03)
Figure C (Leu0f 0000 04)
Figure D (Leu0f 0000 05)
Figure E (Leu0f 0000 06)
Figure F (Leu0f 0000 07)
Figure G (Leu0f 0000 08)
Figure H (Leu0f 0000 09)
Figure I (Leu0f 0000 10)
Figure J (Leu0f 0000 11)
Figure K (Leu0f 0000 12)
Figure L (Leu0f 0000 13)
Package Label – Principal Display Panel – Vial Label (Leu0f 0000 14)
Package Label – Principal Display Panel – Carton (Leu0f 0000 15)
This is a description of a medication labeled as Leuprolide Acetate for subcutaneous injection. The package includes one multi-dose vial containing 1 28mL of the medication. Each 0.2 mL contains Leuprolide acetate, 1 mg, with sodium chloride for tonicity adjustment, benzyl alcohol as preservative, and water for injection. The container closure does not contain natural rubber latex. The usual dosage is 0.2 mL subcutaneously once a day. The medication should be stored below 25°C and protected from light. Manufacturer information indicates it is made in Taiwan by a company called Avenacy. Additional details and instructions can be found in the package insert.*
Package Label – Principal Display Panel – Kit (Leu0f 0000 16)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.